Well, quite apart from the fact that to a large extent "performance" will live or die on the drill bit over which they have little or no control, and they already have freebie options to cover themselves over that, I don't think I can vote "Yes" when they can't even issue an annual report that doesn't require amendment and despite that warning follow it up with the release of an ambiguous Notice of Meeting title, they can't even get that right.
I am astounded that under those circumstances they feel that what they have is not already enough and are asking for more.
On second thoughts maybe they are saying that they need more money before we can expect them to do such mundane things as vet report releases - or if they do vet them, surely they can't be expected do it properly on their existing salaries and incentives. I'm beginning to be embarrassed to be a shareholder, two ASX release in a row requiring correction, what are they doing.
pj
- Forums
- ASX - By Stock
- FAR
- Ann: Notice of Meeting, Performance Rights Plan and rights issue-FAR.AX
FAR
far limited
Add to My Watchlist
0.00%
!
36.0¢

Ann: Notice of Meeting, Performance Rights Plan and rights issue-FAR.AX, page-71
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
36.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.26M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 168182 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 6001 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 161182 | 0.360 |
1 | 32014 | 0.355 |
1 | 6000 | 0.340 |
2 | 17000 | 0.330 |
1 | 4500 | 0.305 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 6001 | 1 |
0.385 | 4502 | 2 |
0.390 | 2691 | 2 |
0.400 | 8600 | 1 |
0.410 | 33333 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
FAR (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online